IW 337

January 28, 2026 Viktor Zarev 0 min read
  1. Insurers scramble to adapt to flat 2027 Medicare Advantage rates.
  2. UnitedHealthcare may lose 1.4M MA customers this year. 
  3. South Carolina measles outbreak achieves dubious record.
  4. Measles outbreaks also take hold in European countries. 
  5. Doctors take a pass on new federal vaccine guidance. 
  6. 50% of Americans may be obese by 2035.
  7. FDA’s CDRH issues report on 2025 accomplishments.
  8. Hospitals get more resident training slots.
  9. Doctors are looking at AI scribes more positively.
  10. Two-thirds of Epic EHR hospitals are using ambient AI.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiology Pharmaceuticals February 9, 2026

Statin Side Effects Might Not be So Bad February 9, 2026

New research in The Lancet suggests that statin underutilization might stem from unfounded safety fears rather than actual risk, after researchers found that 62 out of 66 the drugs’ package-listed adverse effects lack reliable evidence. In an attempt to clear statins’ name, researchers analyzed data from 19 large RCTs to distinguish real statin-associated risks from […]

Cardiology Business February 5, 2026

Medtronic Acquires CathWorks, Expands Cath Lab Presence February 5, 2026

Using AI algorithms to diagnose and assess coronary artery disease for intervention is about to become more mainstream after medtech giant, Medtronic, agreed to exercise its acquisition rights on AI FFR specialist, CathWorks, for $585M up-front. Until now CathWorks’ FFRangio has only been available in the U.S., Europe, and Japan through Medtronic’s distribution network, but […]

Cardiology Pharmaceuticals February 2, 2026

CKM’s True Medication Burden February 2, 2026

As cardiology begins to look at the spectrum of cardiovascular-kidney-metabolic disease, new research in JAMA suggests that CKM treatments might face serious adoption challenges due to the sheer number of Americans who both have the disease and qualify for medications. In a search for just how many eligible patients are out there, researchers examined FDA-approved […]